sysadmin
July 29th, 2004, 07:30
This study looked at the value of preoperative positron emission tomography to help select which patients with congestive heart failure would benefit from bypass surgery. Positron emission tomography was cost-effective in selecting patients for operation. In a hypothetical population of 1,000 patients, using positron emission tomography saved marginally more life-years and cost approximately £3 million less. Using positron emission tomography before coronary artery bypass grafting instead of all patients receiving medical treatment saved lives but was more expensive. The incremental cost per life-year saved was £77,000. The sensitivity analysis showed that the prevalence of hibernation and the survival rate of patients refused revascularization on the basis of the positron emission tomography scan were the areas most likely to influence cost-effectiveness. The authors conclude that PET is cost-effective in this setting. <BR>
<A HREF="http://www.e-locum.net/about.html"><IMG SRC="http://www.e-locum.net/images/prof1.jpg"></A><BR>World renowned nuclear medicine physician Michael N. Maisey was a co-author of this study
http://ats.ctsnetjournals.org/cgi/content/abstract/73/5/1403
Ann Thorac Surg 2002;73:1403-1409
<A HREF="http://www.e-locum.net/about.html"><IMG SRC="http://www.e-locum.net/images/prof1.jpg"></A><BR>World renowned nuclear medicine physician Michael N. Maisey was a co-author of this study
http://ats.ctsnetjournals.org/cgi/content/abstract/73/5/1403
Ann Thorac Surg 2002;73:1403-1409